The Promise of Pharmacogenomics and its Impact on the Pharmaceutical Industry
Details
Speakers
The Promise of Pharmacogenomics and its Impact on the Pharmaceutical Industry
Pharmacogenomics holds the promise of bringing safe and effective medicine to patients. The intersection of genetics and therapeutics will enable patients to receive the best possible individualized drug treatment based upon their genotypes, while helping to mitigate health care costs. Pharmacogenomic studies optimize therapy by understanding the effects of individual genetic variations on drug response.
IBMS is pleased to have a stellar group of speakers for this event. Our distinguished speakers will provide a comprehensive view of current developments in this field as well as a preview of future direction of this emerging field from industry, academia, and the legal perspective.
The IBMS Personalized Medicine meeting is a great way to gain an understanding of the emerging and important field of pharmacogenomics and its impact on the healthcare system from leading experts in the field all in one evening. We look forward to hosting a successful and informative conference.
Additional information
Our work is centered around a series of Focus Areas that we believe are the future of science and technology.
We’re continually developing new technologies, many of which are available for Commercialization.
Our scientists and staffers are active members and contributors to the science and technology communities.